Biovica will attend one of the largest partnering conferences serving the global biotechnology and pharmaceutical industry. The conference attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. This years spring meeting is arranged in Stockholm at Kistamässan.
“With DiviTum™ we provide researchers and pharmaceutical companies with a tool for better evaluation of drug efficacy. DiviTum™ aims to improve the early development process for our partners and form a serum bridge between preclinical & clinical studies, ultimately contributing to give cancer patients the best possible outcome. The BIO-Europe conference in Stockholm is a great opportunity for Biovica to network and showcase our technology”, says Anders Rylander, CEO at Biovica.